A patent review of NLRP3 inhibitors to treat autoimmune diseases

Taylor and Francis Group, Expert Opinion on Therapeutic Patents, 6(33), p. 455-470, 2023

Journal article published in 2023 by Yiming Xu, Savannah Biby, Baljit Kaur

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by